Beyond Air Inc
XAIR
Company Profile
Business description
Beyond Air Inc a commercial-stage medical device and biopharmaceutical company developing a platform of nitric oxide (NO) generators and delivery systems (the LungFit platform) capable of generating NO from ambient air. Its segments are Beyond Air, Beyond Cancer, and NeuroNos. The company generates majority of revenue from Beyond Air. It has developed the Beyond Air NO generator and delivery system which it call LungFit, a novel and precise delivery system that uses NO generated from ambient air with a novel NO generator, the ionizer. Its product and technology includes LungFitPH.
Contact
900 Stewart Avenue
Suite 301
Garden City
New YorkNY11530
USAT: +1 516 665-8200
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 March 2027
Employees
54
Stocks News & Analysis
stocks
What did Morningstar subscribers buy and sell during August?
Earnings season fuels trading activity.
stocks
Tesla: Shares fall as market disappointed with Cybercab launch event
We think Tesla stock is fairly valued.
stocks
The best global tech stocks to buy
These 12 undervalued technology stocks look attractive today.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,008.30 | 23.20 | -0.26% |
| CAC 40 | 8,116.76 | 0.00 | 0.00% |
| DAX 40 | 25,361.15 | 215.30 | -0.84% |
| Dow JONES (US) | 52,040.11 | 340.55 | -0.65% |
| FTSE 100 | 10,608.92 | 61.14 | -0.57% |
| HKSE | 24,954.47 | 320.49 | -1.27% |
| NASDAQ | 26,076.25 | 177.09 | -0.67% |
| Nikkei 225 | 65,270.95 | 128.17 | 0.20% |
| NZX 50 Index | 13,711.01 | 108.42 | -0.78% |
| S&P 500 | 7,591.30 | 45.06 | -0.59% |
| S&P/ASX 200 | 8,819.40 | 18.60 | -0.21% |
| SSE Composite Index | 3,934.40 | 17.10 | -0.43% |